These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 29360474

  • 21. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
    De Burghgraeve T, Kaptein SJ, Ayala-Nunez NV, Mondotte JA, Pastorino B, Printsevskaya SS, de Lamballerie X, Jacobs M, Preobrazhenskaya M, Gamarnik AV, Smit JM, Neyts J.
    PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
    [Abstract] [Full Text] [Related]

  • 22. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
    Sze A, Olagnier D, Hadj SB, Han X, Tian XH, Xu HT, Yang L, Shi Q, Wang P, Wainberg MA, Wu JH, Lin R.
    Viruses; 2017 Oct 03; 9(10):. PubMed ID: 28972551
    [Abstract] [Full Text] [Related]

  • 23. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
    Yamamoto M, Ichinohe T, Watanabe A, Kobayashi A, Zhang R, Song J, Kawaguchi Y, Matsuda Z, Inoue JI.
    Viruses; 2020 Dec 21; 12(12):. PubMed ID: 33371476
    [Abstract] [Full Text] [Related]

  • 24. [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.
    Wan YH, Wu WY, Guo SX, He SJ, Tang XD, Wu XY, Nandakumar KS, Zou M, Li L, Chen XG, Liu SW, Yao XG.
    Acta Pharmacol Sin; 2020 May 21; 41(5):706-718. PubMed ID: 31729469
    [Abstract] [Full Text] [Related]

  • 25. A small-molecule dengue virus entry inhibitor.
    Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG.
    Antimicrob Agents Chemother; 2009 May 21; 53(5):1823-31. PubMed ID: 19223625
    [Abstract] [Full Text] [Related]

  • 26. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative.
    Ayala-Nuñez NV, Jarupathirun P, Kaptein SJ, Neyts J, Smit JM.
    Antiviral Res; 2013 Oct 21; 100(1):238-45. PubMed ID: 23994499
    [Abstract] [Full Text] [Related]

  • 27. Inhibitory effect of doxycycline against dengue virus replication in vitro.
    Rothan HA, Mohamed Z, Paydar M, Rahman NA, Yusof R.
    Arch Virol; 2014 Apr 21; 159(4):711-8. PubMed ID: 24142271
    [Abstract] [Full Text] [Related]

  • 28. Peptide inhibitors of dengue virus and West Nile virus infectivity.
    Hrobowski YM, Garry RF, Michael SF.
    Virol J; 2005 Jun 01; 2():49. PubMed ID: 15927084
    [Abstract] [Full Text] [Related]

  • 29. A Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant Acacia catechu Binds to Dengue Virus and Inhibits Cell Entry.
    Panya A, Sawasdee N, Songprakhon P, Tragoolpua Y, Rotarayanont S, Choowongkomon K, Yenchitsomanus PT.
    Viruses; 2020 Nov 06; 12(11):. PubMed ID: 33172110
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tatanan A from the Acorus calamus L. root inhibited dengue virus proliferation and infections.
    Yao X, Ling Y, Guo S, Wu W, He S, Zhang Q, Zou M, Nandakumar KS, Chen X, Liu S.
    Phytomedicine; 2018 Mar 15; 42():258-267. PubMed ID: 29655694
    [Abstract] [Full Text] [Related]

  • 34. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
    Soto-Acosta R, Bautista-Carbajal P, Syed GH, Siddiqui A, Del Angel RM.
    Antiviral Res; 2014 Sep 15; 109():132-40. PubMed ID: 25017471
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses.
    Flipse J, Diosa-Toro MA, Hoornweg TE, van de Pol DP, Urcuqui-Inchima S, Smit JM.
    Sci Rep; 2016 Jul 06; 6():29201. PubMed ID: 27380892
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.